Bloomberg
Regeneron's Yancopoulos on Hearing Loss Gene Therapy, Weight Loss Drugs
📊
AI Sentiment
Positive
7/10
Regeneron Pharmaceuticals Inc. News
Latest updates and market news for REGN
9 news
Jan 9 - Jan 15, 2026
Page 1
GuruFocus.com
AbbVie Signs US Deal to Cut Drug Prices, Secure Tariff Exemptions
📊
AI Sentiment
Positive
7/10
MT Newswires
Jefferies Adjusts Price Target on Regeneron Pharmaceuticals to $885 From $870, Maintains Buy Rating
📊
AI Sentiment
Positive
7/10
MT Newswires
Raymond James Adjusts PT on Regeneron Pharmaceuticals to $820 From $800, Keeps Outperform Rating
📈
AI Sentiment
Highly Positive
8/10
StockStory
1 Mooning Stock with Exciting Potential and 2 Facing Headwinds
📊
AI Sentiment
Positive
6/10
TheStreet
A big Wall Street flip just changed the Regeneron narrative
📈
AI Sentiment
Highly Positive
9/10
Zacks
Regeneron (REGN) Upgraded to Strong Buy: What Does It Mean for the Stock?
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
Bernstein Adjusts Price Target on Regeneron Pharmaceuticals to $911 From $818, Maintains Outperform Rating
📊
AI Sentiment
Positive
7/10
Share this news page